Detalhe da pesquisa
1.
Striatin plays a major role in angiotensin II-induced cardiomyocyte and cardiac hypertrophy in mice in vivo.
Clin Sci (Lond)
; 138(10): 573-597, 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38718356
2.
PKN2 deficiency leads both to prenatal 'congenital' cardiomyopathy and defective angiotensin II stress responses.
Biochem J
; 479(13): 1467-1486, 2022 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35730579
3.
Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo.
Biochem J
; 479(3): 401-424, 2022 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35147166
4.
Cardiomyocyte BRAF is a key signalling intermediate in cardiac hypertrophy in mice.
Clin Sci (Lond)
; 136(22): 1661-1681, 2022 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36331065
5.
The insulin receptor family and protein kinase B (Akt) are activated in the heart by alkaline pH and α1-adrenergic receptors.
Biochem J
; 478(11): 2059-2079, 2021 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34002209
6.
MAP4K4 expression in cardiomyocytes: multiple isoforms, multiple phosphorylations and interactions with striatins.
Biochem J
; 478(11): 2121-2143, 2021 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34032269
7.
The anti-cancer drug dabrafenib is not cardiotoxic and inhibits cardiac remodelling and fibrosis in a murine model of hypertension.
Clin Sci (Lond)
; 135(14): 1631-1647, 2021 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34296750